ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Identification of proteins interacting with ALK in neuroblastoma. | Dana-Farber Cancer Institute / Rani George | Young Investigator Grants | 2009 | Massachusetts |
Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities | Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD | 'A' Award Grants | 2019 | Massachusetts |
Tyrosine Kinase Mutation Discovery in Neuroblastoma. | Dana-Farber Cancer Institute / Matthew Meyerson, MD, PhD | Innovation Grants | 2006 | Massachusetts |
Genetic Regulators of ER Stress-induced Apoptosis in Pediatric Malignancies | Dana-Farber Cancer Institute / Ujwal Pyati | Young Investigator Grants | 2009 | Massachusetts |
Reversing mSWI/SNF (BAF) Complex Misassembly and Genomic Targeting in Human Synovial Sarcoma | Dana-Farber Cancer Institute / Cigall Kadoch, PhD | 'A' Award Grants | 2017 | Massachusetts |
Using zebrafish to model the molecular origins of pediatric myeloid malignancies and acute myeloid leukemia | Dana-Farber Cancer Institute / Evisa Gjini | Young Investigator Grants | 2011 | Massachusetts |
Novel Approaches to AML Differentiation Therapy | Dana-Farber Cancer Institute / Andrew Lane, MD/PhD | 'A' Award Grants | 2017 | Massachusetts |
In vivo Analysis of Neuroblastoma Pathogenesis using Transgenic Zebrafish | Dana-Farber Cancer Institute / Alfred Tom Look, MD | Innovation Grants | 2011 | Massachusetts |
Dana-Farber/Children’s Hospital Cancer Center Developmental Therapeutics Center of Excellence | Dana-Farber Cancer Institute / Steven DuBois, MD & Wendy London, PhD - Scholars: Melissa Burns, MD; Kevin Campbell, MD; Natalie Collins, MD/PhD; David Shulman, MD | Center of Excellence Grants | 2012 | Massachusetts |
Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma | Dana-Farber Cancer Institute / David Debruyne, PhD | Young Investigator Grants | 2016 | Massachusetts |